NasdaqCM - Delayed Quote USD
Citius Pharmaceuticals, Inc. (CTXR)
0.8746
-0.0454
(-4.93%)
At close: June 13 at 4:00:02 PM EDT
0.8780
+0.00
+(0.39%)
After hours: June 13 at 7:40:51 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 453.91k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HOLUKA EUGENE MYRON Director | Conversion of Exercise of derivative security at price 0.01 per share. | Direct | 36 | Mar 13, 2024 |
| WEBB CAROL A Director | Conversion of Exercise of derivative security at price 0.01 per share. | Direct | 181 | Mar 4, 2024 |
| MAZUR LEONARD L Officer, Director and Beneficial Owner | Purchase at price 0.90 per share. | Direct | 2,000,280 | Sep 27, 2019 |
| HOLUBIAK MYRON Z Chief Executive Officer | Purchase at price 0.90 per share. | Direct | 500,000 | Sep 27, 2019 |
| MAZUR LEONARD L Officer, Director and Beneficial Owner | Purchase at price 1.54 per share. | Direct | 1,799,999 | Apr 3, 2019 |
| HOLUBIAK MYRON Z Chief Executive Officer | Purchase at price 1.54 per share. | Direct | 200,000 | Apr 3, 2019 |
| MAZUR LEONARD L Officer, Director and Beneficial Owner | Purchase at price 1.27 per share. | Direct | 4,000,000 | Aug 13, 2018 |
| HOLUBIAK MYRON Z Chief Executive Officer | Purchase at price 1.27 per share. | Direct | 1,000,000 | Aug 13, 2018 |
| MAZUR LEONARD L Officer, Director and Beneficial Owner | Purchase at price 2.98 per share. | Direct | 499,999 | Mar 29, 2018 |
| HOLUBIAK MYRON Z Chief Executive Officer | Purchase at price 3.09 per share. | Direct | 9,007 | Mar 28, 2018 |
| MAZUR LEONARD L Officer, Director and Beneficial Owner | Purchase at price 4.69 per share. | Direct | 999,467 | Dec 19, 2017 |
| MAZUR LEONARD L Other Executive | Purchase at price 2.68 per share. | Direct | 29,480 | Aug 24, 2017 |
| MAZUR LEONARD L Other Executive | Purchase at price 4.12 per share. | Direct | 1,738,275 | Aug 8, 2017 |
| MAZUR LEONARD L Other Executive | Conversion of Exercise of derivative security at price 3.09 per share. | Direct | 4,780,437 | Aug 8, 2017 |
| MAZUR LEONARD L Director | Purchase at price 0.60 per share. | Direct | 3,000,000 | Mar 30, 2016 |
Related Tickers
EVGN Evogene Ltd.
1.3800
-9.21%
NCNA NuCana plc
0.1149
-24.41%
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%
KZIA Kazia Therapeutics Limited
9.30
-5.01%
SNPX Synaptogenix, Inc.
3.7100
-23.66%
UNCY Unicycive Therapeutics, Inc.
0.6814
+6.82%
PLRZ Polyrizon Ltd.
0.8350
-21.96%
VXRT Vaxart, Inc.
0.7020
+30.73%
CARM Carisma Therapeutics, Inc.
0.4516
-17.62%
PHAT Phathom Pharmaceuticals, Inc.
10.64
+6.08%